Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ OGT 2115
Antiangiogenic. Heparanase inhibitor
Supplier: Tocris Bioscience™ 2710/1
This item is not returnable.
View return policy
Description
OGT 2115 is a heparanase inhibitor (IC50 = 0.4 μM) that displays no major inhibition of human cytochrome P450 isoenzymes (IC50 > 30 μM). Exhibits antiangiogenic properties in vitro (IC50 = 1 μM).Specifications
2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid | |
>98% | |
Soluble to 10mM in DMSO | |
Observed MW: 495.3 |
853929-59-6 | |
1 mg | |
C24H16BrFN2O4 | |
97% |
Safety and Handling
Recommended Storage : Store at Room Temperature
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only